Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Case 3 Sem 2 > COPD > Flashcards

COPD Flashcards

(75 cards)

Start Studying
1
Q

What is COPD?

A

Disease of adults usually 45+ with airflow obstruction that is not fully reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is COPD caused?

A

Long term exposure to toxic particles and gases (usually long term smoking)
Occupational coal miners (cadmium)
Air pollution
Cannabis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Intrinsic risk factors

A

Anti proteinase (a1-anti trypsin) deficiency
Airway hyperreactivity (easily triggered bronchospasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of COPD

A

Productive cough
White/clear sputum
Wheeze
Breathlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis of COPD

A

Evidence of airflow limitation
FEV1 less than 80%
FEV1:FVC ratio less than 70%
PEFR is low
a1 antitrypsin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood gases COPD

A

Hyoxaemia and hypercapnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rust coloured sputum indicates

A

Pneumococcal bacteria (pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Smoking cessation

A

Only intervention proven to decelerate decline in FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bronchodilator treatment COPD

A

mild COPD: B adrenergic agonists (salbutamol)
severe COPD: long term B adrenergic agonists (salmeterol)
Antimuscarinic drugs (ipratropium) more prolonged and greater bronchodilation achieved
Theophyllines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antimuscarinic drugs

A

Stops acetylcholine binding, calcium, stops lung contracting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Theophyllines

A

Prevents and treats wheezing, shortness of breath and chest tightness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Corticosteroids and COPD

A

Airway function may improve considerably
Combination of inhaled corticosteroids with long acting B2 agonists produces further improved eg in breathlessness, reduces frequency and severity of exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antibiotics and COPD

A

Shortens exacerbations, should always be given in acute episodes, may prevent hospital admission and further lung damage
When sputum turns yellow/green

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oxygen therapy COPD

A

Improves survival, prevent progression of pulmonary hypertension, decrease incidence of secondary polycythameia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Polycythaemia

A

Higher amount of RBC, makes blood thicker, harder to flow through blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is 100% oxygen not given to patient?

A

In COPD, less new oxygen going in and less old CO2 coming out, therefore a higher C02 conc in alveoli, patient sensitised to this hypercapnia, relies on hypoxaemia to drive ventilation. Administering oxygen reduces hypoxaemia, reducing respiratory drive whilst CO2 remains high. Patient hypoventilates instead of hyperventilating, respiratory drive reduced = fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aim of oxygen therapy

A

Increase Pa02 to at least 60mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What % oxygen administered to COPD?

A

24-28%, increased to 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Prognosis COPD

A

Poor prognosis predictor: increasing age, worsening airflow limitation (fall in FEV1), Weight loss, pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Emphysema

A

Abnormal permanent enlargement of air spaces distal to terminal bronchiole, destruction of their walls without obvious fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Centriacinar (centrilobular) emphysema

A

Central or proximal parts of acini, formed by respiratory bronchioles are affected, distal alveoli spared, therefore emphysematous and normal airspace’s exist within the same acinus and lobule
Legions more common in upper lobe, particularly apical segments
Walls of emyphysematous spaces contain black pigment
Most common form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Panacinar (panlobular) emphysema

A

Less common
Distension and destruction involves the whole of the acinus, from respiratory bronchiole to terminal blind alveoli
Severe airflow limitation and V/Q mismatch occurs
Occurs in a1 antitrypsin deficiency
Occurs in lower lobes of lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Distal acinar (paraseptal) emphysema

A

Proximal portion of acinus normal, distal part involved
Emphysema adjacent to pleura, along lobular connective tissue septa and margins of lobules
Multiple enlarged airspace’s forming cyst like structures with progressive enlargement (bullae)
Underlies many cases of spontaneous pneumothorax in young adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Irregular emphysema (airspace enlargement with fibrosis)

A

Acinus irregularly involved, associated with scarring, eg resulting from healed inflammatory disease
Clinically asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Pathogenesis of emphysema
COPD characterised by mild chronic inflammation throughout airways, parenchyma, pulmonary vasculature Macrophages, CD8+ and CD4+ T lymphocytes, neutrophils increased in the lung Activated inflammatory cells release mediators capable of damaging lung structures/ sustaining neutrophilic inflammation
26
Protease-antiprotease imbalance hypothesis
Genetic deficiency of antiprotease a1 antitrypsin, enhanced tendency to develop pulmonary emphysema Neutrophils normally isolated in peripheral capillaries, few gain access to alveolar spaces Any stimulus that increases number of leukocytes (neutrophils and macrophages) in the lung or the release of protease containing granules increases Proteolytic activity Low levels of serum a1 antitrypsin, elastic tissue destruction unchecked, emphysema results Emphysema results from destructive effect of high protease activity in subjects with low antiprotease activity
27
a1-antitrypsin
Found in serum, tissue fluids, macrophages A proteinase inhibitor produced in liver, secreted into blood, diffuses into the lung Inhibits Proteolytic enzymes (proteinases) eg neutrophil elastase (capable of destroying alveolar wall connective tissue)
28
Protease-antiprotease imbalance hypothesis and cigarette smoking
Centriacinar form In smokers, neutrophils and macrophages accumulate in alveoli, activate transcription of factor NF-kB switching on genes that encode TNF and chemokines, attract and activate neutrophils Accumulated neutrophils activated and release their granules rich in cellular proteases resulting in tissue damage Smoking enhances elastase activity in macrophages, macrophage elastase can Proteolytically digest antiprotease a1 antitrypsin
29
Oxidant-antioxidant imbalance (smoking)
Normally the lung contains antioxidants (inhibit oxidation) preventing oxidative damage Tobacco smoke contains reactive oxygen species (free radicals), deplete antioxidant mechanisms, inciting tissue damage
30
What increases amount of reactive free radicals in alveoli
Activated neutrophils
31
Secondary consequence of oxidative injury
Inactivation of native proteases, resulting in functional a1 antitrypsin deficiency
32
Elastic tissue in alveolar walls contribute to
Elastic recoil of lung parenchyma
33
Loss of elastic tissue
Causes respiratory bronchioles to collapse in expiration, functional airflow obstruction
34
Inflammation of small airways
Goblet cell Metaplasia with mucus plugging of lumen Inflammatory infiltration of walls with neutrophils, macrophages, B cells , CD4 and CD8 T cells Thickening of bronchioles wall, due to smooth muscle hypertrophy and peribronchial fibrosis These changes narrow bronchioles lumen, airway obstruction
35
Morphology of emphysema
Advanced emphysema produces voluminous lungs Large apical blebs/bullae characteristic of irregular emphysema secondary to scarring/distal acinar emphysema
36
Bullous emphysema
Large subpleural blebs/bullae (spaces more than 1cm diameter in distended state) occur Represent localised accentuations of emphysema and occur near apex Rupture of bullae may give rise to pneumothorax
37
Clinical course emphysema
Clinical symptoms Do not appear until at least 1/3 of functioning pulmonary parenchyma damaged Dyspnoea (first symptom, progressive), cough and wheezing, reduced FEV1, normal FVC (FEV1:FVC ratio reduced), weight loss Barrel chested, dyspneic, prolonged expiration, sits forward hunched over, breathes through pursed lips
38
Dyspnoea (dyspneic)
Shortness of breath
39
Death in emphysema due to
Respiratory acidosis, right sided heart failure, massive collapse in lungs secondary to pneumothorax
40
What is pneumonia?
Infection of lung interstitium, alveoli and airways, resulting in inflammation of the lungs, usually caused by bacteria
41
Pneumonia symptoms
Cough, purulent sputum (rust coloured: streptococcus pneumonia), breathlessness, fever, pleuritic chest pain, consolidation (filling with fluid - proteinaceous fluid/ inflammatory cells cogent airspaces, chest x ray changes
42
Classification of pneumonia
By site/localisation: bronchopneumonia - more patchy alveolar consolidation associated with bronchial and bronchiole inflammation affecting both lower lobes Lobar pneumonia - homogenous consolidation of one or more lung lobes, associated with pleural inflammation By mechanism/pathogen: Bacterial pneumonia, viral pneumonia, aspiration pneumonia (contents of stomach travel up oesophagus and down trachea causing infection in alveoli, making conditions acidic) By locality: CAP (community acquired pneumonia) HAP (hospital acquired pneumonia) VAP (ventilator acquired pneumonia)
43
Defence mechanisms (pneumonia)
Nose (filters, warms, humidifies) Larynx (coughing) Lungs and tract (mucociliary clearance) Cellular/humoral immunity
44
Risk factors for pneumonia
Age, impaired cough (larynx problem), impaired mucociliary clearance (smoking/congenital), immunosupression
45
Clinical examination of pneumonia
Tachypnea, tachycardia, fever, hypotension (due to fluid loss in inflammation)
46
Tachypnea
Fast breathing
47
Pneumonia treatment
Antibiotics -must cover streptococcus pneumonia, cephalosporin (cefuroxime), macrolide (clarithromycin), oral glucocorticoids, oxygen, IV fluids, nutrition
48
Community Acquired Pneumonia (CAP)
Bacterial/viral Bacterial infection follows an upper respiratory tract viral infection Usually caused as a result of infection by streptococcus pneumonia
49
Pathogenesis of CAP
1.Attachment of bacteria to upper respiratory tract epithelium 2. Necrosis of cells 3.inflammatory response 4. This extends to alveoli (interstitial inflammation, inhibition of mucociliary clearance)
50
Streptococcus pneumonia
Gram positive bacteria False positives may be obtained (S. pneumoniae 20% of flora in adults) Presence of numerous neutrophils containing gram positive, lancet shaped diplococci supports diagnosis of pneumococcal pneumonia
51
Streptococcus pneumonia effects
Rapidly ill with high temp (up to 39.5) Pleuritic pain Dry cough Hyperventilation and shallow breathing (affected side of chest moves less, signs of consolidation together with a pleural rub - where inflamed visceral pleura rubs against non inflamed parietal pleura)
52
Hospital acquired pneumonia (HAP)
Result of infection by staphylococcus aureus/ gram negative rods (enterobacterium) New episode of pneumonia at least 2 days after admission to hospital Common in patients with severe underlying disease and immunosuppressive Elderly/mechanical ventilation at risk
53
Aspiration pneumonia
Occurs mainly in debilitated patients, patients that aspirate gastric contents (gag and swallowing reflexes that facilitate aspiration) Resultant pneumonia partly chemical, resulting from irritating effects of gastric acid, partly bacterial Anaerobic bacteria predominate Necrotising, severe and sudden onset, frequent cause of death
54
Fulminant
Severe and sudden
55
Lung abscess (pneumonia)
Swollen and containing pus caused by tissue destruction and necrosis Cavity formation on chest x ray, presence of a fluid level Common cause is aspiration
56
Suppuration
Formation of disease causing matter and discharge of pus
57
Clinical features of lung abscess
Persisting and worsening pneumonia, large quantities of sputum (foul smelling due to growth of anaerobic organisms) Swinging fever, malaise and weight loss
58
Malaise
Discomfort
59
Empyema (pneumonia)
Spread of infection to pleural cavity Presence of pus in pleural cavity Arises from bacterial spread from pneumonia, after a rupture of lung abscess in pleural space Empyema cavity becomes infected with anaerobic organisms, patient severely ill with high fever and neutrophil granulocytosis
60
Yellow/green sputum
Sputum neutrophils, bacterial colonisation/infection. Antibiotics will be effective
61
Blood in sputum
Neoplasm/pulmonary infarct
62
Serous/frothy/pink sputum
Blood present
63
Foamy white sputum
Obstruction Odema Ineffective against antibiotics, may be viral
64
Rusty coloured sputum
Pneumococcal bacteria
65
Erythromycin (macrolides)
Macrolides inhibit bacterial protein synthesis by inhibitory effect on translocation (tRNA shifting from A to P site) A remains occupied, therefore addition of incoming tRNA and its attached amino acid to the polypeptide chain is inhibited, interfering with production of functional proteins Macrolide antibiotics bind reversibly to P site on subunit 50S of bacterial ribosome (bacteriostatic, may be bactericidal at high conc.)
66
Antimicrobial spectrum of erythromycin
Similar to penicillin, safe and effective alternative for penicillin sensitive patients
67
Erythromycin effective against
Gram positive bacteria and spirochaetes, not against gram negative organisms
68
Can resistance against erythromycin occur
Yes
69
Side effects of erythromycin
Gastrointestinal disturbances Hypersensitivity reactions (skin rashes and fever)
70
Cefuroxime (cephalosporin)
Treats pneumonia All B lactam antibiotiss interfere with synthesis of bacterial cell wall peptidoglycan
71
Action of Cefuroxime (cephalosporin)
1. Attacks cell wall 2. Attaches via B lactam ring to the target cell wall (Penicillin binding protein PBP) 3. Changes functional group of protein on cell wall, causes inhibition of transpeptidition enzyme that cross links the peptide chains attached to backbone of peptidoglycan 4. Cell wall weakened and crumbles. Extracellular fluid enters bacteria, leading to death of bacteria 5. Bacteria can respond by producing B lactamase, however cefuroxime is B lactamase resistant
72
Side effects of cefuroxime (cephalosporin)
Hypersensitivity reactions
73
What is Lung fibrosis?
Excessive deposition of collagen and other Extracellular matrix components in lungs “Scarring of the lung”
74
Lung fibrosis symptom
Shortness of breath
75
Pathogenesis of lung fibrosis
Result of chronic injury leading to chronic inflammation associated with: proliferation and activation of macrophages and lymphocytes, production of inflammatory and fibrogenetic growth factors, production of cytokines

Case 3 Sem 2 (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions